The Duke–NUS Medical School (Duke–NUS) is a graduate medical school in Singapore. The school was set up in April 2005 as the Duke–NUS Graduate Medical School, Singapore's second medical school, after the Yong Loo Lin School of Medicine, and before the Lee Kong Chian School of Medicine. It is a collaboration between Duke University in the United States and the National University of Singapore in Singapore. Duke-NUS follows the American model of post-baccalaureate medical education, in which students begin their medical studies after earning a bachelor's degree. Students are awarded degrees from both Duke University and the National University of Singapore.
杜克－新加坡国立大学医学院 (Chinese) | |
 | |
| Type | Medical school |
|---|---|
| Established | April 2005 |
Parent institution | Duke University and NUS |
| Dean | Thomas M. Coffman |
| Location | |
| Website | www |
Outram campus
editThe construction of Duke-NUS Medical School's primary facility, the Khoo Teck Puat Building, started in December 2006.[1] In May 2009, the School shifted from its first campus at Jalan Bukit Merah into the Outram campus of Singapore General Hospital, next to the College of Medicine Building. The 13-storey green-certified building was officially inaugurated by Prime Minister of Singapore Lee Hsien Loong on 28 September 2009.
On 30 November 2010, the strategic collaboration between Duke and NUS was extended by a further five years. On 2 June 2016, the stakeholders extended this through another five-year agreement. During this third phase of the partnership, SingHealth came onboard as Duke-NUS' academic medicine partner. Together, Duke-NUS and SingHealth transformed the campus at Outram into the SingHealth Duke-NUS Academic Medical Centre.[2]
On 13 October 2022, the fourth phase of the Duke-NUS collaboration agreement was signed by the presidents of Duke-NUS' two parent universities at a ceremony held in Durham, North Carolina, extending the partnership for another five years.[3]
Graduate programmes
editBelow are graduate programmes that are offered at Duke-NUS Medical School.[4]
Doctor of Medicine programme
editDuke-NUS' Doctor of Medicine (MD) programme is a four-year programme based on the Duke University School of Medicine curriculum.[5][6] Students who successfully complete the course of study and fulfill all requirements are awarded a joint MD degree from Duke University and the National University of Singapore.
The Duke-NUS curriculum is similar to that of the Duke University School of Medicine, consisting of four years: the first year is for pre-clerkship, the second year for clerkship, the third year for research, and the fourth year for advanced clinical rotations. Duke-NUS employs an extensive team-based learning method called TeamLEAD (Learn, Engage, Apply, Develop). Students prepare for classes with pre-reading materials and recorded lectures. They begin the class with a test, and then proceed to discuss the test questions and other open-ended questions in a small group setting. The faculty act as facilitators for student discussions, moving away from traditional pedagogical teaching.[5]
Prospective students are required to take the Medical College Admission Test (MCAT)[7] or the Graduate Medical School Admissions Test (GMAT). Applicants are also evaluated based on their academic performance, research experience, and evidence of leadership capabilities. [8]
PhD programme
editDuke-NUS offers a Doctor of Philosophy (PhD) programmes in Integrated Biology and Medicine, Clinical and Translational Sciences, as well as Quantitative Biology and Medicine. Graduates from the IBM track are conferred PhD degrees jointly award by Duke University and the National University of Singapore, while graduates from the other two tracks receive their PhD degrees from the National University of Singapore.
MD-PhD programme
editDuke-NUS also offers an MD-PhD programme, where students complete the following: one year of basic science coursework, one year of clinical rotations, four years of research work in Singapore or the United States, and a final year of clinical rotations.
Signature research programmes
editSignature research programmes at Duke-NUS focus on the following areas.[9]
- Cancer and Stem Cell Biology
- Cardiovascular and Metabolic Disorders
- Emerging Infectious Diseases
- Health Services and Systems Research
- Neuroscience and Behavioral Disorders
Research centres
editDuke-NUS hosts several research and medical centres.[10]
- Centre for Aging Research and Education[11]
- Centre for Computational Biology
- Centre for Outbreak Preparedness
- Centre for Quantitative Medicine
- Centre of Regulatory Excellence
- Centre for Technology and Development
- Lien Centre for Palliative Care
- Centre for Clinician-Scientist+ Development
- Centre for Vision Research
- Pre-hospital & Emergency Research Centre
Singhealth Duke-NUS AMC
editThe SingHealth Duke-NUS Academic Medical Centre (AMC) was established by SingHealth and Duke-NUS. Through this partnership in academic medicine, the AMC harnesses the collective strengths of Duke-NUS' medical education and research capabilities, and SingHealth's clinical expertise to bring about improved healthcare and patient outcomes.
Some of the centres launched under this partnership include:[12]
Academic clinical programmes
editGraduates are awarded degrees from both Duke University and the National University of Singapore.
Academic clinical programmes were created for 15 clinical specialties, harnessing the expertise of each discipline across SingHealth and Duke-NUS for cooperation in clinical care, education and research.[17]
COVID-19 research
edit- cPass
cPass is a COVID-19 test kit that Duke-NUS co-developed with biotech company GenScript Biotech Corporation and the Agency for Science, Technology and Research's (A*Star) Diagnostics Development Hub (DxD Hub), capable of checking for signs of a COVID-19 infection in individuals within an hour.[18][19]
Developed by a team led by Professor Wang Linfa, from Duke-NUS' Emerging Infectious Diseases programme, the kit was also the first of its kind to receive emergency authorisation from the United States Food and Drug Administration (FDA).[20]
A precursor of the test was also used to detect Singapore's largest coronavirus infection cluster at the Grace Assembly of God Church.[21]
- Made-in-Singapore Swab Robot
Known as SwabBot, the robot developed by Rena Dharmawan and her team carries out nasal swabbing, helping to address the limitations of manual COVID-19 swabbing as well as to standardise the consistency of swabs taken.[22]
- COVID-19 saliva Amplified Antigen Rapid Test
Co-developed by SingHealth Duke-NUS Academic Medical Centre and the National University of Singapore researchers, this saliva-based COVID-19 Antigen Rapid Test (ART) technology uses a proprietary on-kit amplification technique, enabling detection of the SARS-CoV-2 virus with sensitivity close to that of laboratory-based polymerase chain reaction (PCR) tests, in 15 minutes.[23]
- COVID-19 stories book and microsite
To chronicle the School's research and innovations made in the fight against COVID-19, Duke-NUS launched a book titled Duke-NUS COVID Stories, along with a microsite.[24]
Administration
editSenior management at Duke-NUS Medical School includes the following.[25]
- Thomas M. Coffman (Dean)
- Tan Boon Ooi Patrick (Senior-Vice Dean, Office of Research)
- Karen Chang (Senior Vice-Dean & Group Director, Office of Corporate Services)
- Chow Wan Cheng (Vice-Dean, Office of Academic Medicine)
- Christopher Laing (Vice-Dean, Office of Innovation & Entrepreneurship)
- Shiva Sarraf-Yazdi (Interim Vice-Dean, Office of Education)
Notable faculty
editReferences
edit- ^ "Duke-NUS names its new building after late philanthropist, Tan Sri Khoo Teck Puat".
- ^ "Duke-NUS - About Academic Medicine". DukeNUS.
- ^ "Duke-NUS Medical School in Singapore - Media Releases". DukeNUS.
- ^ "Duke-NUS MD, MD-PhD and PhD Programmes". DukeNUS.
- ^ a b "AAMC Readiness for Reform: Duke – National University of Singapore Case Study Implementing Team-Based Learning for Medical Students" (PDF). Association of American Medical Colleges. Archived from the original (PDF) on 2013-11-04. Retrieved 2013-08-01.
- ^ Kamei, Cook; Puthucheary, Starmer (2012). "21st Century Learning in Medicine: Traditional Teaching versus Team-Based Teaching". Medical Science Educator. 22 (2): 57–64. doi:10.1007/BF03341758. S2CID 56770146. Archived from the original on 2013-11-04. Retrieved 2013-08-01.
- ^ "Class Profile of Duke-NUS Medical School in Singapore". DukeNUS.
- ^ "21st Century Learning in Medicine" (PDF).
- ^ "Signature Programmes". DukeNUS.
- ^ "Medical Research Centres & Institutes | Duke-NUS Medical School". DukeNUS.
- ^ Kok, Xing Hui (June 2, 2015). "New research centre at Duke-NUS to study ageing issues" – via The Straits Times.
- ^ "SingHealth Duke-NUS AMC Homepage". www.singhealthdukenus.com.sg.
- ^ Ng, Huiwen (October 24, 2015). "New surgical skills and simulation centre to meet the needs of more healthcare practitioners" – via The Straits Times.
- ^ "New Institute to Address Global Health Challenges". www.healthxchange.sg.
- ^ Correspondent, Goh Yan HanPolitical (October 8, 2021). "New research institute to focus on maternal and child health in Singapore" – via The Straits Times.
{{cite web}}:|last=has generic name (help) - ^ Correspondent, Rei KurohiTech (April 12, 2019). "New transplant centre to explore ways to increase access to organs" – via The Straits Times.
{{cite web}}:|last=has generic name (help) - ^ "Academic Clinical Programmes | Duke NUS". DukeNUS.
- ^ Goh, Timothy (May 15, 2020). "Singapore develops new test that can swiftly detect if someone has had Covid-19" – via The Straits Times.
- ^ Goh, Timothy (May 16, 2020). "Duke-NUS to co-develop, produce one-of-its-kind test kit with partners" – via The Straits Times.
- ^ Goh, Timothy (November 9, 2020). "Singapore team's Covid-19 neutralising antibody test kit is first to get US FDA approval" – via The Straits Times.
- ^ Goh, Timothy; Kurohi, Rei (February 25, 2020). "Grace Assembly coronavirus mystery solved: Antibody tests linked mega cluster to 2 Wuhan tourists via CNY party and Life Church cluster in a world-first" – via The Straits Times.
- ^ Begum, Shabana (September 21, 2020). "New Covid-19 swab test robot offers safe, more comfortable procedure for patients" – via The Straits Times.
- ^ Tan, Cheryl (December 8, 2021). "Saliva ART developed by S'pore scientists just as accurate as PCR tests, results in 15 minutes" – via The Straits Times.
- ^ "Leaving the Pandemic". Leaving the Pandemic. 2019-01-01. Retrieved 2023-10-16.
- ^ "Duke-NUS - Senior Management". DukeNUS.